Assessment of the therapeutic potential of hesperidin and proteomic resolution of diabetes-mediated neuronal fluctuations expediting Alzheimer's disease. Issue 58 (25th June 2015)

• Record Type: Journal Article
• Authors: Khowal, Sapna; Mustufa, Malik M. A.; Chaudhary, Naveen K.; Naqvi, Samar Husain; Parvez, Suhel; Jain, Swatantra K.; Wajid, Saima
• Is Part Of: RSC advances. Volume 5:Issue 58(2015)
• Page Start: 46965
• Page End: 46980
• Publication Date: 2015-06-25
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c5ra01977j
• Languages: English
• ISSNs: 2046-2069

Abstract

<abstract abstract-type="toc"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <graphic position="anchor" id="ga" xlink:href="ark:/27927/pgjqwqc3fh" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" />Alzheimer's disease (AD) has been proposed as type III diabetes mellitus. Prognosis and early stage diagnosis of AD is essentially required in diabetes to avoid extensive irreversible neuronal damage.</p> </abstract>